Title: Early assessment of treatment response in primary biliary cholangitis: key to timely
management
Version: 2 Date: 06 May 2025
Reviewer's report:
1. Were hepatitis B, hepatitis C and MAFLD included in the exclusion criteria?
2. In Table 5, why was there no significant difference in ALT at diagnosis and a significant
difference in AST? Also, please state based on that the disease was PBC.
Title: Early assessment of treatment response in primary biliary cholangitis: key to timely
management
Version: 2 Date: 06 May 2025
Reviewer's report:
1. Were hepatitis B, hepatitis C and MAFLD included in the exclusion criteria?
2. In Table 5, why was there no significant difference in ALT at diagnosis and a significant
difference in AST? Also, please state based on that the disease was PBC.
Please review this paper.
user
Title: Early assessment of treatment response in primary biliary cholangitis: key to timely
management
Version: 2 Date: 06 May 2025
Reviewer's report:
1. Were hepatitis B, hepatitis C and MAFLD included in the exclusion criteria?
2. In Table 5, why was there no significant difference in ALT at diagnosis and a significant
difference in AST? Also, please state based on that the disease was PBC.
assistant